A New Weapon Against Cancer: Checkpoint Inhibitors, A Double-Edged Sword
Checkpoint inhibitors, a novel class of anticancer medications, embrace a unique approach to counter tumors.
Source: forbes.com
Pd 1 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pd 1. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pd 1 Today - Breaking & Trending Today
2026 VW ID.1 Makes Scripted Debut As Tiny Crossover With Targeted Sub-€20,000 Price
Volkswagen's ID.1 entry-level electric vehicle is due in 2026, and these renderings try to decipher its design. Is it a yay or a nay?
Source: autoevolution.com
Triple Combination Therapies in RCC: Clinical Trial Insights
Experts discuss the potential of triple combination therapies for high-risk renal cell carcinoma (RCC) patients and the challenges posed by their toxicity profiles, emphasizing the need for compelling clinical trial data.
Source: onclive.com
Lindenwood athletes react to university cutting 10 athletic programs
Lindenwood announced in early December that 10 athletic programs, nine varsity sports, would be cut at the end of their respective seasons.For one wrestler, Lindenwood was the perfect fit until the university called a meeting on Dec. 1.
Source: firstalert4.com
ESMO 2023 Insights: SunRISe-1 Study of TAR-200 in BCG-Unresponsive Bladder Cancer
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Source: ajmc.com